Products
Technologies
Applications
Services
Resources
Selection Guides
About
Protein tyrosine kinase 2 beta Inhibitors (IC50, Ki)
Structure | Compound Name | Standard Type | Standard Values (in nM) |
|---|---|---|---|
 | CID 11598628 | IC50 | 11.0 [1], 31.0 [2], 63.0 [3] |
 | PF-00562271 free base | IC50 | 13.0 [1], 14.0 [2] |
 | 4-[[4-[[(1R,2R)-2-(Dimethylamino)cyclopentyl]amino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]-N-methylbenzenesulfonamide | IC50 | 88.0 [1], 140.0 [2], 154.0 [3] |
 | 4-N-[(1R,2R)-2-(Dimethylamino)cyclopentyl]-2-N-(4-methylsulfonylphenyl)-5-(trifluoromethyl)pyrimidine-2,4-diamine | IC50 | 60.0 [1], 95.0 [2] |
 | 8-(4-Ethylphenyl)-5-Methyl-2,5-Dihydropyrazolo[4,3-C][2,1]benzothiazine 4,4-Dioxide | IC50 | 6800.0 [1], 9000.0 [2], 10000.0 [3] |
References
This online resource may be cited as follows
MLA | "Quest Database™ Protein tyrosine kinase 2 beta Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 30 Dec. 2025, https://www.aatbio.com/data-sets/protein-tyrosine-kinase-2-beta-inhibitors-ic50-ki. | |
APA | AAT Bioquest, Inc. (2025, December 30). Quest Database™ Protein tyrosine kinase 2 beta Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/protein-tyrosine-kinase-2-beta-inhibitors-ic50-ki. | |
| BibTeX | EndNote | RefMan |